Clinical trial

Anti-Inflammatory Effects of Pioglitazone

NCT00722631

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2007-05-01

PhaseNA

Study timeline

Study start (unknown)2007-05-01Date precision: month

Registry last updated2012-09-27

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Impaired Glucose Toleranceunresolved

Type 2 Diabetes Mellitusunresolved

Atherosclerosisunresolved

Interventions

PioglitazoneDRUG · verified · RxNorm: pioglitazone

GlimepirideDRUG · verified · RxNorm: glimepiride

Sponsors & collaborators

Kurume Universitylead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00722631 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.